{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:56:49Z","timestamp":1780052209130,"version":"3.53.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T00:00:00Z","timestamp":1691625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI16\/01373"],"award-info":[{"award-number":["PI16\/01373"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>The knowledge of the aetiology of Beh\u00e7et disease (BD), an immune-mediated vasculitis, is limited. HLA-B, mainly HLA-B51, and HLA-A molecules are associated with disease, but the ultimate cause of this association remains obscure. There is evidence that NK cells participate in the etiopathology of BD. NK cells have activator and inhibitor surface receptors, like the KIR and the NKG2 families. Classical HLA-class I molecules (A, B and C) are keys in the activity control of the NK because they are KIR ligands. Most NKG2 receptors bind HLA-E, which presents only nonapeptides derived from the signal peptide of other class-I molecules.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study investigates the contribution of the pair HLA-E and ligand, nonapeptide derived from the 3-11 sequence of the signal peptides of class I classical molecules, to the susceptibility to BD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We analyzed the frequency of the HLA-derivated nonapeptide forms in 466 BD patients and 444 controls and an HLA-E functional dimorphism in a subgroup of patients and controls. Results: In B51 negative patients, the frequency of VMAPRTLLL was lower (70.4% versus 80.0% in controls; P=0.006, Pc=0.04, OR=0.60, 95%CI 0.41-0.86), and the frequency of VMAPRTLVL was higher (81.6% versus 71.4% in controls; P=0.004, Pc=0.03, OR=1.78, 95%CI 1.20-2.63). In homozygosity, VMAPRTLLL is protective, and VMAPRTLVL confers risk. The heterozygous condition is neutral. There were no significant differences in the distribution of the HLA-E dimorphism.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Our results explain the association of BD with diverse HLA-A molecules, reinforce the hypothesis of the involvement of the NK cells in the disease and do not suggest a significant contribution of the HLA-E polymorphism to disease susceptibility.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2023.1080047","type":"journal-article","created":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T01:15:08Z","timestamp":1691716508000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The complex HLA-E-nonapeptide in Beh\u00e7et disease"],"prefix":"10.3389","volume":"14","author":[{"given":"\u00c1ngel Lu\u00eds","family":"Casta\u00f1o-N\u00fa\u00f1ez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco-Antonio","family":"Montes-Cano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9-Ra\u00fal","family":"Garc\u00eda-Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norberto","family":"Ortego-Centeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Jos\u00e9","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard","family":"Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genaro","family":"Gra\u00f1a-Gil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"S\u00e1nchez-Burs\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Rosa","family":"Juli\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Solans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana-Celia","family":"Barnosi-Mar\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"G\u00f3mez de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Fanlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Rodr\u00edguez-Carballeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rodr\u00edguez-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Camps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Jose","family":"Alegre-Sancho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Mart\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda Francisca","family":"Gonz\u00e1lez-Escribano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,8,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2009.02.011","article-title":"Beh\u00e7et\u2019s disease\u2013a contemporary review","volume":"32","author":"Mendes","year":"2009","journal-title":"J Autoimmun"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/art.24642","article-title":"HLA-B51\/B5 and the risk of beh\u00e7et\u2019s disease: a systematic review and meta-analysis of case-control genetic association studies","volume":"61","author":"de Menthon","year":"2009","journal-title":"Arthritis Rheum"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2551","article-title":"Identification of multiple independent susceptibility loci in the HLA region in behcet's disease","volume":"45","author":"Hughes","year":"2013","journal-title":"Nat Genet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1406575111","article-title":"Behcet disease-associated MHC class I residues implicate antigen binding and regulation of cell-mediated cytotoxicity","volume":"111","author":"Ombrello","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2015.08.013","article-title":"The immunogenetics of behcet's disease: a comprehensive review","volume":"64","author":"Takeuchi","year":"2015","journal-title":"J Autoimmun"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161305","article-title":"Genetic analysis with the immunochip platform in beh\u00e7et disease. identification of residues associated in the HLA class I region and new susceptibility loci","volume":"11","author":"Ortiz-Fern\u00e1ndez","year":"2016","journal-title":"PloS One"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.622306","article-title":"The role of natural killer cells in autoimmune diseases","volume":"12","author":"Kucuksezer","year":"2021","journal-title":"Front Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.9.6293","article-title":"Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-b with KIR3DL1","volume":"181","author":"Sanjanwala","year":"2008","journal-title":"J Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1385\/IR:35:3:263","article-title":"The CD94\/NKG2 family of receptors: from molecules and cells to clinical relevance","volume":"35","author":"Borrego","year":"2006","journal-title":"Immunol Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/eji.1830270517","article-title":"The human major histocompatibility complex class ib molecule HLA-e binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9","volume":"27","author":"Braud","year":"1997","journal-title":"Eur J Immunol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1385\/IR:30:1:029","article-title":"The role of CD94\/NKG2 in innate and adaptive immunity","volume":"30","author":"Gunturi","year":"2004","journal-title":"Immunol Res"},{"key":"B12","unstructured":""},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/tan.12965","article-title":"New insights in HLA-e polymorphism by refined analysis of the full-length gene","volume":"89","author":"Olieslagers","year":"2017","journal-title":"HLA"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M208268200","article-title":"HLA-e allelic variants. correlating differential expression, peptide affinities, crystal structures, and thermal stabilities","volume":"278","author":"Strong","year":"2003","journal-title":"J Biol Chem"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92643-V","article-title":"Criteria for diagnosis of behcet's disease. international study group for behcet's disease","volume":"335","author":"Wechsler","year":"1990","journal-title":"Lancet."},{"key":"B16","doi-asserted-by":"publisher","first-page":"R145","DOI":"10.1186\/ar4328","article-title":"HLA and non-HLA genes in beh\u00e7et's disease: a multicentric study in the Spanish population","volume":"15","author":"Montes-Cano","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"B17","unstructured":""},{"key":"B18","unstructured":"CarstensenB\n            PlummerM\n            LaaraE\n            HillsM\n          r package version 2.472022"},{"key":"B19","doi-asserted-by":"publisher","first-page":"R49","DOI":"10.1186\/ar3292","article-title":"Associations between the HLA-a polymorphism and the clinical manifestations of behcet's disease","volume":"13","author":"Kang","year":"2011","journal-title":"Arthritis Res Ther"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2018.1517364","article-title":"HLA class I in Egyptian patients with beh\u00e7et's disease: new association with susceptibility, protection, presentation and severity of manifestations","volume":"48","author":"Elfishawi","year":"2019","journal-title":"Immunol Invest"},{"key":"B21","doi-asserted-by":"publisher","first-page":"4426","DOI":"10.1038\/s41598-019-40824-y","article-title":"The association analysis between HLA-A*26 and beh\u00e7et's disease","volume":"9","author":"Nakamura","year":"2019","journal-title":"Sci Rep"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1407307111","article-title":"HLA-B*51 the primary risk in beh\u00e7et disease","volume":"111","author":"Wallace","year":"2014","journal-title":"Proc Natl Acad Sci U.S.A."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.10.4951","article-title":"HLA-e surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences","volume":"160","author":"Lee","year":"1998","journal-title":"J Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/18.15.4250","article-title":"Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94\/NKG2-a and the activating receptor CD94\/NKG2-c to HLA-e","volume":"18","author":"Val\u00e9s-G\u00f3mez","year":"1999","journal-title":"EMBO J"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/s1097-2765(00)80053-2","article-title":"Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-e","volume":"1","author":"O'Callaghan","year":"1998","journal-title":"Mol Cell"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2008.01.098","article-title":"Subtle changes in peptide conformation profoundly affect recognition of the non-classical MHC class I molecule HLA-e by the CD94\u2013NKG2 natural killer cell receptors","volume":"377","author":"Hoare","year":"2008","journal-title":"J Mol Biol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.192.5.613","article-title":"Analysis of qa-1.(b) peptide binding specificity and the capacity of CD94\/NKG2A to discriminate between qa-1-peptide complexes","volume":"192","author":"Kraft","year":"2000","journal-title":"J Exp Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.171.3.1369","article-title":"Analysis of HLA-e peptide-binding specificity and contact residues in bound peptide required for recognition by CD94\/NKG2","volume":"171","author":"Miller","year":"2003","journal-title":"J Immunol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.5.2878","article-title":"Interactions between NKG2x immunoreceptors and HLA-e ligands display overlapping affinities and thermodynamics","volume":"174","author":"Kaiser","year":"2005","journal-title":"J Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2007.10.013","article-title":"The heterodimeric assembly of the CD94-NKG2 receptor family and implications for human leukocyte antigen-e recognition","volume":"27","author":"Sullivan","year":"2007","journal-title":"Immunity"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.160.1.171","article-title":"Reduced cell surface expression of HLA-c molecules correlates with restricted peptide binding and stable TAP interaction","volume":"160","author":"Neisig","year":"1998","journal-title":"J Immunol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15924","article-title":"Structural and regulatory diversity shape HLA-c protein expression levels","volume":"8","author":"Kaur","year":"2017","journal-title":"Nat Commun"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1111\/imr.12319","article-title":"A bird's eye view of NK cell receptor interactions with their MHC class I ligands","volume":"267","author":"Saunders","year":"2015","journal-title":"Immunol Rev"},{"key":"B34","doi-asserted-by":"publisher","first-page":"eaag1672","DOI":"10.1126\/sciimmunol.aag1672","article-title":"Class I HLA haplotypes form two schools that educate NK cells in different ways","volume":"1","author":"Horowitz","year":"2016","journal-title":"Sci Immunol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/cei.13292","article-title":"HLA-e: exploiting pathogen-host interactions for vaccine development","volume":"196","author":"Sharpe","year":"2019","journal-title":"Clin Exp Immunol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"R171","DOI":"10.1186\/ar2860","article-title":"HLA-e gene polymorphism associates with ankylosing spondylitis in Sardinia","volume":"11","author":"Paladini","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12233","article-title":"Deletion of the activating NKG2C receptor and a functional polymorphism in its ligand HLA-e in psoriasis susceptibility","volume":"22","author":"Zeng","year":"2013","journal-title":"Exp Dermatol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/cei.12696","article-title":"Polymorphisms within the human leucocyte antigen-e gene and their associations with susceptibility to rheumatoid arthritis as well as clinical outcome of anti-tumour necrosis factor therapy","volume":"182","author":"Iwaszko","year":"2015","journal-title":"Clin Exp Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2018-000677","article-title":"Non-classical human leucocyte antigens in ankylosing spondylitis: possible association with HLA-e and HLA-f","volume":"4","author":"Santos","year":"2018","journal-title":"RMD Open"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20215496","article-title":"Dimorphism of HLA-e and its disease association","volume":"20","author":"Kanevskiy","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.2006.00742.x","article-title":"HLA-E*0101 and HLA-G*010101 reduce the risk of behcet's disease","volume":"69","author":"Park","year":"2007","journal-title":"Tissue Antigens"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1080047\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T01:15:13Z","timestamp":1691716513000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2023.1080047\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,10]]},"references-count":41,"alternative-id":["10.3389\/fimmu.2023.1080047"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2023.1080047","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,10]]},"article-number":"1080047"}}